Therefore, the search for novel BACE-1 inhibitors as potential therapeutics for Alzheimer’s disease (AD) has been undertaken by many scientists from both academia and the pharmaceutical companies [13–18]. This evidence concerns the gene BACE1 and Alzheimer disease.